Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

West Pharmaceutical Services, Inc. (WST) Profit Margins

Over the twelve months to 2026-06-30, West Pharmaceutical Services, Inc. (WST) had gross margin 36.8%, operating margin 20.5%, net margin 17.0%, free cash flow margin 13.1%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

WSTWest Pharmaceutical Services, Inc.Follow WST — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
27.6B
P/E TTM
50.2
Dividend yield
0.2%
52-week
—
Next earnings
29 Oct, in 5 days
LineFY2010
Dec 10		FY2011
Dec 11		FY2012
Dec 12		FY2013
Dec 13		FY2014
Dec 14		FY2015
Dec 15		FY2016
Dec 16		FY2017
Dec 17		FY2018
Dec 18		FY2019
Dec 19		FY2020
Dec 20		FY2021
Dec 21		FY2022
Dec 22		FY2023
Dec 23		FY2024
Dec 24		FY2025
Dec 25		TTM
Jun 26		Trend
Gross margin28.8%28.5%30.6%31.8%31.5%32.6%33.2%32.1%31.8%32.9%35.8%41.5%39.4%38.3%34.5%35.9%36.8%
Operating margin8.2%9.2%10.7%11.9%12.8%9.2%12.9%14.1%14.0%16.1%19.0%26.6%25.4%22.9%19.7%19.0%20.5%
Net margin5.9%6.3%6.4%8.2%8.9%6.8%9.5%9.4%12.0%13.1%16.1%23.4%20.3%20.1%17.0%16.1%17.0%
FCF margin6.1%3.0%4.4%5.0%5.0%5.8%3.3%8.3%10.7%13.1%13.9%11.7%15.2%14.1%9.6%15.3%13.1%

USD billions · SEC XBRL

West Pharmaceutical Services, Inc. — questions

What is West Pharmaceutical Services, Inc.'s gross margin?
36.8% over the twelve months to 2026-06-30.
What is West Pharmaceutical Services, Inc.'s operating margin?
20.5% over the twelve months to 2026-06-30.
What is West Pharmaceutical Services, Inc.'s net profit margin?
17.0% over the twelve months to 2026-06-30.

Every figure on this page comes from West Pharmaceutical Services, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.